Fund Holdings — Darwin Global Management, Ltd.

Total Portfolio Value:
$3.76B
Total Bought:
$1.85B
Total Sold:
$1.96B
Net Transaction:
-$112.37M
Notable People:
Sarah Elizabeth Monime
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Revolution Medicines, Inc.(RVMD)2,211,01810,629,822+8,418,804$204.98M$2.05B54.45%+$1.84B
Insmed Incorporated(INSM)16,805,1846,431,163-10,374,021$2.58B$673.60M17.91%-$1.90B
Belite Bio, IncADS(BLTE)3,057,4123,077,219+19,807$456.10M$456.59M12.14%+$483.5K
ABIVAX Société AnonymeADS(ABVX)3,468,6573,621,583+152,926$352.07M$348.22M9.26%-$3.85M
Roivant Sciences Ltd.SHS(ROIV)6,797,3006,747,300-50,000$179.52M$234.33M6.23%+$54.82M
Dianthus Therapeutics, Inc.(DNTH)17,3570-17,357$1.46M$0—-$1.46M
Page 1 of 1
Darwin Global Management, Ltd. — 13F Holdings — Q2 2026 | TickerTrail